Akira Homma

Summary

Affiliation: Rio de Janeiro
Country: Brazil

Publications

  1. doi request reprint Vaccine research, development, and innovation in Brazil: a translational science perspective
    Akira Homma
    Bio Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
    Vaccine 31:B54-60. 2013
  2. doi request reprint The Brazilian vaccine manufacturers' perspective and its current status
    Akira Homma
    Bio Manguinhos Fiocruz, Pavilhão Rocha Lima, Manguinhos, Rio de Janeiro, Brasil
    Biologicals 37:173-6. 2009
  3. ncbi request reprint [Vaccines, immunization and technological innovation: an update]
    Akira Homma
    Instituto de Tecnologia em Imunobiológicos de Bio Manguinhos, Rio de Janeiro RJ
    Cien Saude Colet 16:445-58. 2011
  4. ncbi request reprint Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures
    Maria Beatriz Borges
    Bio Manguinhos, Fundacao Oswaldo Cruz, Av Brasil, 4365 Manguinhos, Rio de Janeiro, RJ 21040 360, Brazil
    Virus Genes 36:35-44. 2008
  5. ncbi request reprint Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
    Reinaldo de Menezes Martins
    Assessoria Clínica, Rio de Janeiro, RJ, Brasil
    Mem Inst Oswaldo Cruz 103:711-8. 2008

Collaborators

  • Luiz Antonio Bastos Camacho
  • Rugimar Marcovistz
  • Maria Beatriz Borges
  • Reinaldo de Menezes Martins
  • Patricia Cristina Neves Feliciano de Souza
  • Tatiana Guimarães de Noronha
  • Eliane Matos dos Santos
  • Glayse Glayde Barbosa
  • Marcos S Freire
  • Elena Caride
  • Maria de Lourdes Sousa Maia
  • Andrea Marques Vieira da Silva
  • Alfredo V Jabor
  • José Marcus N Malachias
  • Maria Cristina Ferreira Lemos
  • Ricardo Galler

Detail Information

Publications5

  1. doi request reprint Vaccine research, development, and innovation in Brazil: a translational science perspective
    Akira Homma
    Bio Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
    Vaccine 31:B54-60. 2013
    ..We also discuss the lessons learned from the Brazilian experience in the implementation of governmental policies on vaccine innovation that could be applicable to other developing countries...
  2. doi request reprint The Brazilian vaccine manufacturers' perspective and its current status
    Akira Homma
    Bio Manguinhos Fiocruz, Pavilhão Rocha Lima, Manguinhos, Rio de Janeiro, Brasil
    Biologicals 37:173-6. 2009
    ....
  3. ncbi request reprint [Vaccines, immunization and technological innovation: an update]
    Akira Homma
    Instituto de Tecnologia em Imunobiológicos de Bio Manguinhos, Rio de Janeiro RJ
    Cien Saude Colet 16:445-58. 2011
    ..Brazil has also established a new innovation policy, creating new laws as well as subsidizing projects in technological innovation and modernization of production infra-structure...
  4. ncbi request reprint Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures
    Maria Beatriz Borges
    Bio Manguinhos, Fundacao Oswaldo Cruz, Av Brasil, 4365 Manguinhos, Rio de Janeiro, RJ 21040 360, Brazil
    Virus Genes 36:35-44. 2008
    ..This study shows that the measles CAM-70 vaccine virus is highly adapted to its cultivation conditions and that its genetic stability contributes, in part, to the safety profile of the vaccine...
  5. ncbi request reprint Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
    Reinaldo de Menezes Martins
    Assessoria Clínica, Rio de Janeiro, RJ, Brasil
    Mem Inst Oswaldo Cruz 103:711-8. 2008
    ..Adverse events rates were comparable among the vaccine groups. The Brazilian DTP/Hib vaccine demonstrated an immunogenicity and reactogenicity profile similar to that of the reference vaccine...